OptimizeRx Corporation (OPRX) Earnings History
Annual and quarterly earnings data from 2007 to 2025
Loading earnings history...
OPRX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OPRX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 67.3% | 10.7% | 4.7% |
| 2024 | 64.5% | -14.9% | -21.8% |
| 2023 | 60.0% | -36.9% | -24.6% |
| 2022 | 62.4% | -19.7% | -18.3% |
| 2021 | 58.1% | 0.6% | 0.6% |
Download Data
Export OPRX earnings history in CSV or JSON format
Free sign-in required to download data
OptimizeRx Corporation (OPRX) Earnings Overview
As of May 8, 2026, OptimizeRx Corporation (OPRX) reported trailing twelve-month net income of $5M, reflecting +124.5% year-over-year growth. The company earned $0.26 per diluted share over the past four quarters, with a net profit margin of 4.7%.
Looking at the long-term picture, OPRX's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2025, representing a new all-time high.
OptimizeRx Corporation maintains positive profitability with a gross margin of 67.3%, operating margin of 10.7%, and net margin of 4.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including HCAT (-$178M net income, -57.2% margin), DOCS ($239M net income, 39.1% margin), PRVA ($3.08B net income, 1.1% margin), OPRX has outperformed on profitability metrics. Compare OPRX vs HCAT →
OPRX Earnings vs Peers
Earnings metrics vs comparable public companies
OPRX Historical Earnings Data (2007–2025)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5M | +125.5% | $12M | $0.27 | 4.7% | 10.7% |
| 2024 | -$20M | -14.5% | -$14M | $-1.10 | -21.8% | -14.9% |
| 2023 | -$18M | -53.6% | -$26M | $-1.03 | -24.6% | -36.9% |
| 2022 | -$11M | -3125.4% | -$12M | $-0.64 | -18.3% | -19.7% |
| 2021 | $378,079 | +117.1% | $361,100 | $0.02 | 0.6% | 0.6% |
| 2020 | -$2M | +29.8% | -$2M | $-0.15 | -5.1% | -4.9% |
| 2019 | -$3M | -1488.4% | -$4M | $-0.23 | -12.8% | -15.0% |
| 2018 | $226,344 | +110.8% | $180,132 | $0.02 | 1.1% | 0.8% |
| 2017 | -$2M | -36.7% | -$2M | $-0.21 | -17.3% | -17.6% |
| 2016 | -$2M | -158.6% | -$2M | $-0.16 | -19.9% | -20.4% |
See OPRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OPRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OPRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOPRX — Frequently Asked Questions
Quick answers to the most common questions about buying OPRX stock.
Is OPRX growing earnings?
OPRX EPS is $0.26, with earnings growth accelerating to +124.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $5M.
What are OPRX's profit margins?
OptimizeRx Corporation net margin is +4.7%, with operating margin at +10.7%. Below-average margins reflect competitive or cost pressures.
How consistent are OPRX's earnings?
OPRX earnings data spans 2007-2025. The accelerating earnings trend is +124.5% YoY. Historical data enables comparison across business cycles.